Trial Site Detail

 

Drug:
CPI-613
Trial:
Phase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer Patients
Conditions: Solid Tumors
Trial Status:
Terminated

 

Eastchester Center for Cancer

     
Bronx , NY 10469
USA

 

Principal Investigator:
Avi S. Retter, MD
Contact:
Avi S Retter, M.D. 718-732-4000 retter@eastchestercenter.com Karen Hoffman, M.D. (718) 732-4029 karen@eastchestercenter.com
Activation Status of this Site:
Closed
Notes about this Site:
Eastchester Center for Cancer Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.